Introduction
Pancreatic islet transplantation is a promising new mode of treatment for type 1 diabetes. 1 Successful outcomes from pancreatic islet transplantation could lead to resolution of the complications associated with type 1 diabetes that lead to mortality and morbidity. 2, 3 However, the potential advantages and clinical successes of pancreatic islet transplantation are dependent on development of innovative biomaterial strategies. These strategies are required to fulfill the critical needs for success of pancreatic islet transplantation by improving islet cell retention, viability, and functionality. In response to these needs, peptide amphiphile (PA)-based biomaterials that closely mimic the islet cell microenvironment and extracellular matrix proteins have been garnering increasing attention. [4] [5] [6] [7] Peptide amphiphiles are molecules that consist of a hydrophilic, functional peptide sequence coupled to a hydrophobic alkyl tail. [8] [9] [10] The amphiphilic nature of the molecule drives the self-assembly of PAs into a three-dimensional nanomatrix, and inclusion of multifunctional bioactive cues in the functional peptide sequence regulate islet cell behavior.
For this study, we developed a peptide amphiphile nanomatrix that incorporates a laminin-derived cell adhesive ligand (Tyr-Ile-Gly-Ser-Arg), a matrix metalloprotease-2 degradable site (Gly-Thr-Ala-Gly-Leu-Ile-Gly-Gln), 9 and a nitric oxide (NO)
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lim et al donor (Lys-Lys-Lys-Lys-Lys) [11] [12] [13] [14] to provide cells with the requisite bioactive cues. Laminin is a major component of the islet cell extracellular matrix, and laminin-derived sequences have been previously investigated, with favorable outcomes. 15 Moreover, our previous study showed that the laminin cell adhesive ligand, Tyr-Ile-Gly-Ser-Arg, enhances survival and function of MIN-6 beta cells, and the matrix metalloprotease-2 degradable site allows for cell-mediated degradation of the nanomatrix, thereby promoting cell migration and production of native extracellular matrix. 9, 16, 17 Tunable NO release from this nanomatrix has been shown to occur in a controlled biphasic manner, with a burst release followed by sustained release over a 30-day period. 11, 12 Previous studies of this PA nanomatrix have shown great potential for applications in cardiovascular implant devices such as stents and vascular grafts. 11, 13 The nanomatrix can be self-assembled into two-dimensional coatings or three-dimensional nanomatrix gels. [18] [19] [20] It has been shown to promote endothelial cell adhesion and proliferation 11, 12 as well as endothelial progenitor cell adhesion and differentiation.
14 Therefore, the nanomatrix has the potential to stimulate and support angiogenesis.
Thus, the goal of this work was to study the effect of the NO-releasing PA nanomatrix on the viability and functionality of MIN-6 beta cells, which have similar physiologic features to islets. 21 The PA nanomatrix is composed of two PAs, ie, one PA containing the laminin-derived cell adhesive ligand (YIGSR) linked to the matrix metalloprotease-2 degradable site (GTAGLIGQ) to form PA-YIGSR, and the second PA containing a polylysine NO donor linked to the matrix metalloprotease-2 degradable site to form PA-KKKKK. PA-YIGSR and PA-KKKKK were mixed in a 9:1 molar ratio based on previous studies, [11] [12] [13] [14] and reacted with pure NO to form NO-releasing PA, called PA-YK-NO. Self-assembly of PA-YK-NO into uniform nanofibers and controlled, biphasic NO release have been previously demonstrated. 11 However, the role of NO in islet cell biology remains a source of ambiguity and controversy. The lack of NO donors that can release NO in a controlled, sustained manner can lead to results that cannot be reliably interpreted. 22 Some studies suggest a detrimental role, where NO mediates the inflammatory reaction in response to engrafted islet cells. [23] [24] [25] [26] [27] This has been evidenced by elevated expression of interleukin-1β and inducible nitric oxide synthase in regions of pancreatic islet allotransplantation. 28, 29 However, some studies suggest that NO stimulates insulin production and cell viability. [30] [31] [32] [33] This would suggest that the role of NO in islet cell biology may be concentration-dependent. Furthermore, conventional NO donors do not provide the islet cells with other bioactive cues that promote cell viability and functionality. This study therefore provides the added opportunity of studying the effect of controlled NO release on islet cells. We hypothesized that controlled NO release in synergy with multifunctional bioactive cues incorporated into the PA nanomatrix can improve islet cell viability and functionality. 18, 20 To alkylate with palmitic acid, a mixture of o-benzotriazole-N,N,N,N′-tetramethyluronium hexafluorophosphate, diisopropylethylamine, and dimethylformamide was used, and cleavage and deprotection were achieved using a mixture of trifluoroacetic acid, deionized water, triisopropylsilane, and anisole (40:1:1:1) for 3 hours at room temperature. The peptide amphiphiles precipitated in cold ether were lyophilized and characterized by matrix-assisted laser desorption ionization time of flight mass spectrometry.
Materials and methods

Preparation of peptide amphiphiles
Preparation of NO-releasing Pa-YK-NO nanomatrices
As documented in previous work, a mixture of PA-YIGSR and PA-KKKKK at a 9:1 molar ratio was reacted with NO gas to generate PA-YK-NO. 11 In order to make NO-releasing PA nanomatrices, 120 µL of a 0.1% wt stock PA-YK-NO solution (pH 7.4) was prepared and dispensed into 48-well tissue culture plates (BD Biosciences, San Jose, CA, USA) with serial dilutions to make different PA-YK-NOs, ie, 130 µmol PA-YK-NO, 65 µmol PA-YK-NO, 32. 
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Nitric oxide-releasing peptide amphiphile nanomatrix of 95% air and 5% CO 2 . 7 Dulbecco's modified Eagle's medium containing 25 mmol/L glucose supplemented with 15% fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA, USA), 100 units/mL penicillin (Invitrogen, Carlsbad, CA, USA), 100 µg/mL streptomycin (Invitrogen), 100 µg/mL L-glutamine (Invitrogen), and 5 µl/L β-mercaptoethanol (Gibco, Carlsbad, CA, USA) was used to culture the MIN-6 cells. The cells were seeded at a density of 42,000 per cm 2 and incubated for 3 and 7 days, with plates from 7-day cultivations refilled with fresh medium at 3 days.
glucose-stimulated insulin secretion assay
To assess MIN-6 functionality in response to glucose, glucosestimulated insulin secretions at 3 and 7 days were performed for 2 hours in each condition with 22 mmol/L KrebsRinger bicarbonate buffer solutions (25 mmol/L HEPES, 115 mmol/L NaCl, 24 mmol/L NaHCO 3 , 5 mmol/L KCl, 1 mmol/L MgCl 2 , 2.5 mmol/L CaCl 2 , 0.1% bovine serum albumin, and 22 mmol/L D-glucose, pH 7.4). Using an Ultra Sensitive Rat Insulin ELISA kit (Crystal Chem Inc, Downers Grove, IL, USA), the collected samples were quantified and normalized by DNA content to obtain the secreted insulin values. The DNA content was quantified using a fluorometric PicoGreen DNA kit (Molecular Probes, Eugene, OR, USA) with a microplate fluorescent reader (Synergy HT, Bio-Tek Instruments, Winooski, VT, USA).
caspase 3/7 activity in MIN-6 cells cultured on Pa-YK-NO nanomatrices
The caspase activity of MIN-6 cells cultured on four different PA-YK-NOs was assayed using the Caspase-Glo 3/7 assay kit (Promega, Madison, WI, USA) to assess cellular apoptosis. Briefly, each PA was coated onto a white, opaque 96-well plate, and MIN-6 cells (42,000 per cm 2 ) were cultured for 3 and 7 days. At each time point, the cells were washed with phosphate-buffered saline, and 100 µL of fresh medium and 100 µL of the buffered Caspase-Glo substrate were added. After 3 hours, the amount of caspase activity was evaluated by luminescence (Synergy HT, Bio-Tek Instruments).
evaluation of cellular behavior on Pa-YK-NO nanomatrices MIN-6 cells were cultured on four different PA-YK-NOs for 3 and 7 days. At each time point, the media was aspirated, and the cells were rinsed with phosphate-buffered saline.
MIN-6 cell viability for each condition was assessed using the Live/Dead Assay Kit (Molecular Probes Inc) consisting of calcein AM and ethidium homodimer-1.
Quantitative real-time polymerase chain reaction
Using Trizol regent (Invitrogen), total RNA was collected for all samples in each condition at days 3 and 7. For measurement of ins1 and PDX-1 gene expression, all samples were incubated for 2 hours in the presence of glucose (22 mM) and then subjected to RNA extraction. The isolated samples were pelleted, dried in ethanol, and resuspended in nuclease-free water. DNase treatments were carried out (TURBO DNase, Ambion, Austin, TX, USA) before performing quantitative real-time polymerase chain reaction. The RNA concentration of each sample was measured with an ND-1000 UV spectrophotometer (Nanodrop, Wilmington, DE, USA), and 1 µg of isolated RNA was then reverse-transcribed into cDNA using a iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA, USA) according to the manufacturer's instructions. All quantitative real-time polymerase chain reactions were carried out using a Prism 7000 Sequence Detection System (Applied Biosystems, Foster City, CA, USA) with the iQ SYBR Green Supermix (Bio-Rad). The primers used in this study are described in Table 1 , and 18S rRNA was used as the internal standard (18 s RNA forward: 5′-AGT CCC TGC CCT TTG TAC ACA-3′, reverse: 5′-GAT CCG AGG GCC TCA CTA AAC-3′). The measured values were normalized to the internal standard and calculated using the 2 -∆∆Ct method. After 18S rRNA normalization, gene expression levels were presented as the fold ratio relative to those of the control group (tissue culture plate).
Statistical analysis
All experiments were performed independently four times, and the normalized values for glucose-stimulated insulin secretion were expressed as the mean ± standard deviation. One-way analysis of variance was used to examine for Results and discussion evaluation of cellular behavior on the four different Pa-YK-NOs
Four different PA-YK-NOs were used for this study, ie, 130 µmol, 65 µmol, 32.5 µmol, and 16.25 µmol (Figure 1) . A PA-YK-NO was composed of two PAs, ie, an extracellular matrix mimetic PA and a NO-releasing PA combined in a 9:1 molar ratio. The extracellular matrix mimetic PA, referred to as PA-YIGSR, contained a cell-adhesive sequence of TyrIle-Gly-Ser-Arg (YIGSR), which has been shown to improve MIN-6 cell survival as well as function. Similarly, the NOreleasing PA had a NO-donating sequence Lys-Lys-Lys-LysLys (KKKKK). Dispensing different concentrations of the PA-YK-NO solution, four different PA-YK-NO nanomatrices were created and used to evaluate MIN-6 cellular behavior in response to NO. All PA-YK-NOs were characterized and confirmed to release NO in a physiologically acceptable concentration over one month. MIN-6 cells were attached and grown with similar cellular behavior in each PA-YK-NO nanomatrix (Table 2) . Although the average number of cells was slightly greater in the control group at 7 days relative to the PA-YK-NO substrate groups, all PA-YK-NO substrates showed similar growth behavior, with comparable cell viability and cell concentrations. MIN-6 cell viability on the four different PA-YK-NOs was similar, indicating that all the PA-YK-NOs were biocompatible (Figure 2) .
evaluation of functional behavior on the four different Pa-YK-NO nanomatrices
Despite the negative effect on beta cells, recent studies indicate that physiologically acceptable NO exhibits positive effects as well. 22, 34 Enhancing several pathways involved in insulin gene expression, exogenous NO has been shown to stimulate insulin secretion. When cultured on PA-YK-NO nanomatrices, glucose-stimulated insulin secretion responses (22 mM) for both 3 and 7 days of cultivation were either better or at the same level as the control, indicating that NO in low concentrations may have a beneficial effect on the functionality of MIN-6 cells. Excluding the highest NO dose, ie, 130 µmol PA-YK-NO, all NO-releasing PA nanomatrices had beneficial effects on MIN-6 functionality. Additionally, on 65 µmol PA-YK-NO, MIN-6 cells demonstrated the highest level of insulin secretion response, with 32.5 µmol PA-YK-NO having the second best effect over 7 days (Figure 3) . At 3 days, MIN-6 cells showed significantly improved insulin functionality on three of the four NO-releasing PA nanomatrices, whereas 16.25 µmol of PA-YK-NO did not show an initial improved response to glucose. This demonstrates that the initial release of NO by the majority of the PA-YK-NO nanomatrices stimulates MIN-6 cells to respond better to glucose, and indicates that the sustained low NO concen- 
Quantitative real-time polymerase chain reaction gene expression analysis
Previous studies indicate that a stimulatory effect of exogenous NO relates to the gene transcription factor PDX-1, which regulates insulin gene expression. Campbell et al found that PDX-1 upregulated by NO improved insulin gene expression, concluding that NO at low levels could play a regulatory role on insulin secretion in MIN-6 cells. 33 At 3 days, relatively higher amounts of PA-YK-NO (130 µmol PA-YK-NO and 65 µmol PA-YK-NO) showed increased PDX-1 gene expression when compared with the control and 16.25 µmol of PA-YK-NO (Figure 4 ). This upregulation of insulin genes in the higher PA-YK-NOs at 3 days indicates that an initial sustained release of NO by the PA-YK-NOs could have short-term beneficial effects for MIN-6 cells ( Figure 5 ). After 7 days, the 16.25 µmol and 32.5 µmol PA-YK-NO nanomatrices showed improved PDX-1 gene expression, resulting in a significant increase in insulin gene expression (Figures 6 and 7 ). These results demonstrate that the beneficial functional role of NO exerted by the biomimetic NO-releasing PAs resulted from upregulation of the PDX-1 gene, which corresponded to the increase in insulin gene expression.
Seven can release NO in a sustained manner over time, while promoting cell adhesion onto the extracellular matrix mimetic surface of the PA-YK-NO. This mechanism potentially has a dual effect as indicated by the fact the nanofibrous matrix could be utilized to both enhance islet functionality and improve islet engraftment by promoting NO-mediated angiogenesis post transplantation, thus enhancing islet survival. 35, 36 NO is responsible for increasing endothelial cell proliferation, inhibiting apoptosis, and stimulating endothelial cell migration, thereby inducing the revascularization essential for successful islet transplantation.
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Conclusion
Based on recent findings regarding the beneficial role of NO, the aim of this study was to investigate the effect of biomimetic NO donors, which not only provide the native beta cell microenvironment through laminin-1 mimetic peptides but also release NO in a controlled manner over time. Nitric oxide-releasing PA nanomatrices showed a beneficial effect on glucose-stimulated insulin secretion, implying that this NO-producing scaffold could be utilized for improving pancreatic islet transplantation. Specifically, this study shows that there is a specific range of NO concentration that has a beneficial effect (Figure 8 ). Creating a biomimetic NOreleasing scaffold that releases NO continuously within a physiologically acceptable concentration range resulted in an improved response to glucose in MIN-6 beta cells. It was demonstrated that sustained release of NO by PA-YK-NO between 32.5 µmol and 65 µmol upregulates both PDX-1 and insulin gene expression, leading to improved functional responses of MIN-6 cells to glucose (22 mM). These findings are thought to be due to sustained release of NO because a similar level of apoptosis was observed between PA-YK-NOs, implying that the cell viability and survival rate were comparable with that of the control (Figure 9 ). In conclusion, sustained NO release at low concentrations from NO-releasing PA nanomatrices increases MIN-6 functionality, implying that NO has a multifaceted concentration-dependent effect on beta cells. Thus, the NO-releasing PA nanomatrix is a potential biomaterial for pancreatic islet transplantation, which is presently limited by technical problems such as angiogenesis and cell death.
